Codexis (CDXS) Gross Margin (2010 - 2026)

Codexis (CDXS) recorded quarterly Gross Margin of 86.46% in Q1 2026, down 8.75% quarter-over-quarter from 94.75% in Q4 2025, and up 2268.0% on a YoY basis from 3.65% in Q1 2025.

Codexis (CDXS) Gross Margin (2010 - 2026) Analysis & Trends

Codexis' Gross Margin history runs 17 years deep, the most recent figure standing at 86.46% for Q1 2026.

  • In Q1 2026, Gross Margin rose 2268.0% year-over-year to 86.46%; the TTM figure through Mar 2026 stood at 88.9% (up 1733.0% YoY), while the FY2025 annual figure was 86.73%, up 1418.0% from the prior year.
  • Gross Margin was 86.46% for Q1 2026 at Codexis, down from 94.75% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 94.75% in Q4 2025 to a low of 36.44% in Q2 2023.
  • Historically, Gross Margin has averaged 69.16% across 5 years, with a median of 71.34% in 2025.
  • The sharpest annual moves came in 2023 and 2024: Gross Margin sank 3422 bps in 2023, then soared 4021 bps in 2024.
  • A 5-year view of Gross Margin shows it stood at 57.29% in 2022, then fell by 25 bps to 42.76% in 2023, then soared by 94 bps to 82.97% in 2024, then increased by 14 bps to 94.75% in 2025, then fell by 9 bps to 86.46% in 2026.
  • The last three Gross Margin figures came in at 86.46% (Q1 2026), 94.75% (Q4 2025), and 71.34% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - -
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - -
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 79.04%
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - -
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 86.85%
9 Abivax 94.37 Bn 94.37 Bn - -
10 Codexis 236.00 Mn 170.86 Mn 13.18 Mn 86.46%

Historic Data

Download Data
DateValue
Mar 31, 2026 86.46%
Dec 31, 2025 94.75%
Sep 30, 2025 71.34%
Jun 30, 2025 86.31%
Mar 31, 2025 63.78%
Dec 31, 2024 82.97%
Sep 30, 2024 66.36%
Jun 30, 2024 56.61%
Mar 31, 2024 71.56%
Dec 31, 2023 42.76%
Sep 30, 2023 75.76%
Jun 30, 2023 36.44%
Mar 31, 2023 65.17%
Dec 31, 2022 57.29%
Sep 30, 2022 71.61%
Jun 30, 2022 70.66%
Mar 31, 2022 75.89%
Dec 31, 2021 72.22%
Sep 30, 2021 81.32%
Jun 30, 2021 83.04%